Novozymes A/S Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
NESN | Nestlé | Outperform |
11
|
CHF92.20 | CHF115.58 | 19.31% | 13 | CHF241.68B |
PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
BAS | BASF | Outperform |
12
|
49.16€ | 49.50€ | 13.91% | 2 | 43.87€B |
BN | Danone | Outperform |
11
|
58.66€ | 55.47€ | 9.10% | 2 | 37.65€B |
GIS | General Mills Inc | Hold |
18
|
$69.99 | $68.63 | 2.87% | 13 | $39.51B |
GIVN | Givaudan | Hold |
14
|
CHF3.95k | CHF3.14k | -2.43% | 8 | CHF36.41B |
CTVA | Corteva | Outperform |
12
|
$53.91 | $61.72 | 18.72% | 1 | $37.68B |
DD | DuPont de Nemours | Outperform |
17
|
$78.31 | $75.38 | 4.71% | 14 | $32.74B |
DSFIR | DSM-Firmenich | Outperform |
18
|
105.70€ | 114.60€ | 13.53% | 0 | 28.04€B |
BAYN | Bayer | Hold |
5
|
27.35€ | 45.15€ | 9.69% | 4 | 26.87€B |
IFF | International Flavors & Fragra... | Hold |
15
|
$83.99 | $84.46 | 3.58% | 17 | $21.44B |
MKC | McCormick & Company | Hold |
12
|
$74.55 | $72.03 | 0.60% | 1 | $19.84B |
K | Kellanova | Hold |
13
|
$56.98 | $59.19 | 5.30% | 10 | $19.47B |
EMSN | EMS-CHEMIE HOLDING | Hold |
18
|
CHF737.00 | CHF657.14 | -13.57% | 6 | CHF17.24B |
TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
SY1 | Symrise | Outperform |
18
|
100.70€ | 106.97€ | 11.22% | 5 | 14.08€B |
KRZ | Kerry Group | Outperform |
18
|
80.80€ | 96.27€ | 23.14% | 9 | 14.02€B |
ALB | Albemarle | Outperform |
11
|
$119.00 | $154.93 | 21.85% | 17 | $14.14B |
AKZA | Akzo Nobel N.V. | Outperform |
18
|
62.14€ | 79.42€ | 24.72% | 16 | 10.60€B |
EMN | Eastman Chemical Co | Outperform |
11
|
$94.76 | $96.03 | 10.81% | 6 | $11.11B |
CHR | Chr. Hansen Holding A/S | - |
16
|
kr549.60 | kr71.11 | -100.00% | 0 | kr72.33B |
EVK | Evonik Industries | Outperform |
18
|
19.55€ | 20.64€ | 2.30% | 14 | 9.11€B |
BARN | Barry Callebaut | Outperform |
18
|
CHF1.48k | CHF1.88k | 4.45% | 0 | CHF8.12B |
CRDA | Croda International Plc | Outperform |
18
|
£46.19 | £65.12 | 10.41% | 6 | £6.43B |
AKE | Arkema | Outperform |
18
|
97.05€ | 110.07€ | 13.34% | 12 | 7.26€B |
INGR | Ingredion | Outperform |
18
|
$114.30 | $121.71 | 11.11% | 7 | $7.52B |
FMC | FMC | Outperform |
12
|
$57.77 | $66.89 | 14.77% | 0 | $7.37B |
GL9 | Glanbia | Outperform |
18
|
17.84€ | 16.42€ | 13.79% | 7 | 4.66€B |
CLN | Clariant | Outperform |
18
|
CHF13.78 | CHF16.11 | 8.85% | 6 | CHF4.53B |
ASH | Ashland | Outperform |
17
|
$94.50 | $89.30 | 16.40% | 7 | $4.78B |
512070 | UPL | Outperform |
18
|
Rp507.00 | Rp680.36 | 8.48% | 22 | Rp380.56B |
JMAT | Johnson Matthey Plc | Hold |
16
|
£17.57 | £19.13 | 13.83% | 9 | £3.21B |
600299 | Bluestar Adisseo | Outperform |
18
|
¥9.98 | ¥9.81 | 4.21% | 0 | ¥26.77B |
4005 | Sumitomo Chemical Company | Hold |
18
|
¥345.60 | ¥411.36 | 4.17% | 0 | ¥551.81B |
SOLB | Solvay | Hold |
17
|
30.41€ | 125.53€ | -2.99% | 2 | 3.19€B |
KEMIRA | Kemira Oyj | Outperform |
18
|
20.42€ | 17.49€ | 2.84% | 4 | 3.14€B |
TATE | Tate & Lyle | Outperform |
16
|
£6.52 | £8.58 | 30.37% | 2 | £2.62B |
SXT | Sensient Technologies | Buy |
18
|
$73.65 | $72.00 | 7.26% | 1 | $3.10B |
LXS | LANXESS | Hold |
16
|
26.53€ | 31.82€ | 1.77% | 11 | 2.29€B |
ARYN | ARYZTA | Buy |
10
|
CHF1.75 | CHF2.23 | 27.43% | 2 | CHF1.73B |
VCT | Victrex | Hold |
18
|
£12.60 | £16.49 | 22.14% | 5 | £1.10B |
CRBN | Corbion N.V. | Outperform |
14
|
20.54€ | 24.42€ | 21.71% | 5 | 1.21€B |
ELM | Elementis | Outperform |
16
|
£1.42 | £1.73 | 50.00% | 3 | £835.38M |
GNC | Greencore Group | Outperform |
15
|
£1.32 | £1.04 | -18.18% | 4 | £607.60M |
SYNT | Synthomer | Outperform |
18
|
£2.62 | £26.20 | 4.96% | 4 | £425.27M |
CBUS | Cibus | Outperform |
0
|
$17.11 | $22.00 | 46.11% | 1 | $368.67M |
CDXS | Codexis | Buy |
6
|
$3.11 | $5.83 | 60.77% | 3 | $198.96M |
MBII | Marrone Bio Innovations | - |
6
|
$0.80 | $1.30 | -100.00% | 0 | $145.56M |
EVGN | Evogene | - |
6
|
₪2.67 | ₪0.00 | -100.00% | 0 | ₪175.00M |
PHC | Plant Health Care |
11
|
£0.04 | £0.53 | 1200.00% | 1 | £13.01M |